BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34762806)

  • 41. G-Quadruplex-Binding Proteins: Promising Targets for Drug Design.
    Shu H; Zhang R; Xiao K; Yang J; Sun X
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tailoring a lead-like compound targeting multiple G-quadruplex structures.
    Amato J; Platella C; Iachettini S; Zizza P; Musumeci D; Cosconati S; Pagano A; Novellino E; Biroccio A; Randazzo A; Pagano B; Montesarchio D
    Eur J Med Chem; 2019 Feb; 163():295-306. PubMed ID: 30529547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural recognition of the MYC promoter G-quadruplex by a quinoline derivative: insights into molecular targeting of parallel G-quadruplexes.
    Dickerhoff J; Dai J; Yang D
    Nucleic Acids Res; 2021 Jun; 49(10):5905-5915. PubMed ID: 33978746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deciphering RNA G-quadruplex function during the early steps of HIV-1 infection.
    Amrane S; Jaubert C; Bedrat A; Rundstadler T; Recordon-Pinson P; Aknin C; Guédin A; De Rache A; Bartolucci L; Diene I; Lemoine F; Gascuel O; Pratviel G; Mergny JL; Andreola ML
    Nucleic Acids Res; 2022 Nov; 50(21):12328-12343. PubMed ID: 36453997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. G-Quadruplex-Based Fluorescent Turn-On Ligands and Aptamers: From Development to Applications.
    Umar MI; Ji D; Chan CY; Kwok CK
    Molecules; 2019 Jun; 24(13):. PubMed ID: 31262059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short LNA-modified oligonucleotide probes as efficient disruptors of DNA G-quadruplexes.
    Chowdhury S; Wang J; Nuccio SP; Mao H; Di Antonio M
    Nucleic Acids Res; 2022 Jul; 50(13):7247-7259. PubMed ID: 35801856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ligand-induced native G-quadruplex stabilization impairs transcription initiation.
    Li C; Wang H; Yin Z; Fang P; Xiao R; Xiang Y; Wang W; Li Q; Huang B; Huang J; Liang K
    Genome Res; 2021 Sep; 31(9):1546-1560. PubMed ID: 34400476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ligand Selectivity by Inserting GCGC-Tetrads into G-Quadruplex Structures.
    Cao Y; Yang L; Ding P; Li W; Pei R
    Chemistry; 2020 Nov; 26(64):14730-14737. PubMed ID: 32839998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New triazole-attached quinoxalines selectively recognize the telomeric multimeric G-quadruplexes and inhibit breast cancer cell growth.
    Hu MH; Lin JH
    Int J Biol Macromol; 2023 Jun; 241():124548. PubMed ID: 37094649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting G-Quadruplex DNA for Cancer Chemotherapy.
    Debbarma S; Acharya PC
    Curr Drug Discov Technol; 2022; 19(3):e140222201110. PubMed ID: 35156574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimization of G-Quadruplex Ligands through a SAR Study Combining Parallel Synthesis and Screening of Cationic Bis(acylhydrazones).
    Reznichenko O; Leclercq D; Franco Pinto J; Mouawad L; Gabelica V; Granzhan A
    Chemistry; 2023 Jan; 29(4):e202202427. PubMed ID: 36286608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. G-quadruplex: Flexible conformational changes by cations, pH, crowding and its applications to biosensing.
    Nishio M; Tsukakoshi K; Ikebukuro K
    Biosens Bioelectron; 2021 Apr; 178():113030. PubMed ID: 33524709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BCL2 G quadruplex-binding small molecules: Current status and prospects for the development of next-generation anticancer therapeutics.
    Singh M; Gupta R; Comez L; Paciaroni A; Rani R; Kumar V
    Drug Discov Today; 2022 Sep; 27(9):2551-2561. PubMed ID: 35709931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. De Novo Design of Selective Quadruplex-Duplex Junction Ligands and Structural Characterisation of Their Binding Mode: Targeting the G4 Hot-Spot.
    Díaz-Casado L; Serrano-Chacón I; Montalvillo-Jiménez L; Corzana F; Bastida A; Santana AG; González C; Asensio JL
    Chemistry; 2021 Apr; 27(20):6204-6212. PubMed ID: 33368678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modeling G4s in chromatin context confirms partial nucleosome exclusion and reveals nucleosome-disrupting effects of the least selective G4 ligands.
    Pavlova I; Barinov N; Novikov R; Severov V; Iudin M; Vedekhina T; Larin A; Babenko V; Aralov A; Gnuchikh E; Sardushkin M; Klinov D; Tsvetkov V; Varizhuk A
    Biochimie; 2023 Jan; 204():8-21. PubMed ID: 36063975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-Molecule Analysis of the Improved Variants of the G-Quadruplex Recognition Protein G4P.
    Gaur P; Bain FE; Honda M; Granger SL; Spies M
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluorescence intercalator displacement assay for screening G4 ligands towards a variety of G-quadruplex structures.
    Tran PL; Largy E; Hamon F; Teulade-Fichou MP; Mergny JL
    Biochimie; 2011 Aug; 93(8):1288-96. PubMed ID: 21641961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Octahedral Cobalt(III) Complex with Axial NH
    Ruehl CL; Lim AHM; Kench T; Mann DJ; Vilar R
    Chemistry; 2019 Jul; 25(41):9691-9700. PubMed ID: 31087710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beyond small molecules: targeting G-quadruplex structures with oligonucleotides and their analogues.
    Cadoni E; De Paepe L; Manicardi A; Madder A
    Nucleic Acids Res; 2021 Jul; 49(12):6638-6659. PubMed ID: 33978760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural Basis of Pyridostatin and Its Derivatives Specifically Binding to G-Quadruplexes.
    Liu LY; Ma TZ; Zeng YL; Liu W; Mao ZW
    J Am Chem Soc; 2022 Jul; 144(26):11878-11887. PubMed ID: 35749293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.